Efficacy and adverse effects of moclobemide
Fahy, T.J.
Lancet 343(8895): 475-476
1994
ISSN/ISBN: 0140-6736 PMID: 7905963 Document Number: 427985
Document emailed within 1 workday
Related Documents
Menkes, D.B.; Wood, K.; Wooods, D. 1994: Efficacy and adverse effects of moclobemide Lancet 343(8895): 476Tiller, J.W.; Bouwer, C.; Behnke, K. 1997: Moclobemide for anxiety disorders: a focus on moclobemide for panic disorder International Clinical Psychopharmacology 12(Suppl 6): S27-S30
Graves, D.; Cocohoba, J.; Gruta, C.; Goldschmidt, R. 2004: Potential adverse effects and inferior efficacy in ARV treatment Journal of the National Medical Association 96(5): 692
Wynn, R.L. 2010: Antidepressant drugs: new reports on adverse effects and efficacy General Dentistry 58(6): 474-477
2011: Denosumab. Limited efficacy in fracture prevention, too many adverse effects Prescrire International 20(117): 145-148
Sukcharoen, N.; Aribarg, A.; Kriangsinyos, R.; Chanprasit, Y.; Ngeamvijawat, J. 1996: Contraceptive efficacy and adverse effects of testosterone enanthate in Thai men Journal of the Medical Association of Thailand 79(12): 767-773
Obel, E.B. 1977: Oral contraception. Efficacy, adverse effects, contraindications, choice of preparation Ugeskrift for Laeger 139(26): 1525-1536
Quatresooz, P.; Rorive, A.; Paquet, P.; Piérard-Franchimont, C.; Piérard, G.E. 2009: Cutaneous adverse effects predicting the efficacy of targeted antineoplastic therapies Revue Medicale de Liege 64(5-6): 347-350
Mroczek, W.J. 1983: Indapamide: clinical pharmacology, therapeutic efficacy in hypertension, and adverse effects PharmacoTherapy 3(2 Part 1): 61-67
Xu, J.; Guo, J.-g.; Wu, X.-h.; Zeng, X.-j.; Yang, W.-p.; Yang, G.-b.; Zheng, J.; Zhou, X.-n. 2009: Efficacy and adverse effects of film coated praziquantel for treatment of schistosomiasis japonica Zhonghua Yu Fang Yi Xue Za Zhi 43(8): 718-722
Prosvetov, I.V.; Spesivtsev, O.G.; Gal'chanskaia, L.D. 1990: A decline in the efficacy of hyposensitization due to the adverse effects of antitubercular agents against a background of immuno-correction Problemy Tuberkuleza 1990(11): 54-55
Janiec, W.; Pietryka, B.; Sliwiński, L.; Leszczyńska, J. 1985: Adverse effects of nonsteroid anti-inflammatory drugs. I. Adverse effects of salicylic, phenylacetic and propionic acids Wiadomosci Lekarskie 38(22): 1613-1619
Bielory, L.; Russin, J.; Zuckerman, G.B. 2004: Clinical efficacy, mechanisms of action, and adverse effects of complementary and alternative medicine therapies for asthma Allergy and Asthma Proceedings 25(5): 283-291
Wesnes, K.A.; Simpson, P.M.; Christmas, L.; Anand, R.; McClelland, G.R. 1989: The effects of moclobemide on cognition Journal of Neural Transmission. Supplementum 28: 91-102
Stricker, B.H.; Ottervanger, J.P.; van der Klauw, M.M. 1994: Registration of suspected adverse effects by the Bureau Adverse Effects Drugs; research activities in 1993 Nederlands Tijdschrift Voor Geneeskunde 138(42): 2110-2113
Gerdén, B. 2005: The Medical Products Agency about SSRi to pregnant women and adverse effects on the fetus. Long-term adverse effects are not proved, documentation is insufficient, more research is necessary Lakartidningen 102(10): 791
Janiec, W.; Pietryka, B.; Pytlik, M.; Leszczyńska, J. 1985: Adverse effects of non-steroidal anti-inflammatory drugs. II. Adverse effects of heterocyclic enols Wiadomosci Lekarskie 38(24): 1745-1750
Nowakowska, E.; Chodera, A.; Kus, K.; Rybakowski, J. 1998: Anxiolytic and memory improving effects of moclobemide Arzneimittel-Forschung 48(6): 625-628
Mayerhofer, K.; Bodner-Adler, B.; Bodner, K.; Leodolter, S.; Kainz, C. 2000: Paclitaxel/carboplatin as first-line chemotherapy in advanced ovarian cancer: efficacy and adverse effects with special consideration of peripheral neurotoxicity Anticancer Research 20(5c): 4047-4050
Sepúlveda, B. 1970: Adverse effects of contraceptives. II. Adverse effects of contraceptive steroids on the liver Gaceta Medica de Mexico 100(8): 823-831